Why orphan drugs are a key part of pharma’s future? 30 November 2012 / By andre / Clinical Trials, Drug Discovery, Manufacturing, Market Access, Orphan Drugs, Partnering & Investment, Regulation and Government / 0 comments
How to bring an orphan drug to market – why is there legislation for rare diseases? 25 June 2012 / By Carly / Orphan Drugs / 0 comments
Criticism of the Orphan Drug Legislation 26 August 2011 / By matt turner / Orphan Drugs, Regulation and Government / 0 comments
